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Although cigarette smoking has been recognized as a risk factor for the development of several inter-
stitial lung diseases, the relationship between smoking and nonspeciﬁc interstitial pneumonia (NSIP) has
not yet been fully elucidated. We here present a case of ﬁbrotic NSIP with mild emphysema in an elderly
male with normal pulmonary function, whose symptoms, serum KL-6 level, and high-resolution
computed tomography ﬁndings of interstitial changes markedly improved without medication
following the cessation of smoking. Our case suggests that smoking may be an etiological factor in some
patients with NSIP and that early smoking cessation before a clinically detectable decline in pulmonary
function may be critical for smokers with idiopathic NSIP.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Cigarette smoking has been recognized as a risk factor for the
development of several interstitial lung diseases (ILDs), such as
pulmonary Langerhans cell histiocytosis, respiratory bronchiolitis-
associated ILD, and desquamative interstitial pneumonia (DIP) [1].
Although these diseases have a relatively good prognosis following
smoking cessation, typically in combination with corticosteroid
therapy, the causative role of smoking in ﬁbrotic lung diseases re-
mains controversial.
Nonspeciﬁc interstitial pneumonia (NSIP) is characterized by
the temporally homogenous involvement of alveolar septa by
inﬂammation and ﬁbrosis, in contrast to the heterogeneity of usual
interstitial pneumonia (UIP). Most patients with interstitial pneu-
monia showing a pathological NSIP pattern are of unknown etiol-
ogy, and the clinical features of ﬁbrotic NSIP resemble idiopathic
pulmonary ﬁbrosis (IPF)/UIP. Although the prognosis of ﬁbrotic
NSIP was documented to be better than that of IPF/UIP [2], the: þ81 88 843 6385.
hinohara).
Ltd. This is an open access article urelationship between smoking and NSIP has not yet been fully
elucidated.
In this report, we present a case of ﬁbrotic NSIP with mild
emphysema in an elderlymale, whose symptoms, serum KL-6 level,
and high-resolution computed tomography (HRCT) ﬁndings
markedly improved without medication after smoking cessation.Case report
A 66-year-oldmanwho enjoyed karaoke visited our department
because of respiratory difﬁculties during singing. He smoked a pack
of cigarettes a day for 45 years. He had a history of essential hy-
pertension and hyperlipidemia, but not pulmonary or autoimmune
diseases or occupational exposure to ﬁbrogenic substances. Chest
CT revealed mild emphysema and faint interstitial changes in the
lungs. Since neither obstructive nor restrictive impairments were
detected on pulmonary function tests, we recommended that the
patient quit smoking without medication. However, he was unable
to quit, and the appearance of a dry cough, increment in serum KL-
6, and gradual worsening of interstitial changes on CT were
observed during the next one and a half years without a decline in
pulmonary function. Therefore, the patient was admitted for
further examinations including bronchoscopy.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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lungs. Laboratory values were as follows: white blood cell count,
8420/ml with normal differentiation; hemoglobin,16.4 g/dl; platelet
count, 21.4  104/ml; C-reactive protein, 0.25 mg/dl; serum KL-6,
930 U/ml (<500); anti-nuclear antibody, positive at 1:40 dilution
based on the Japanese criteria with a homogenous and speckled
pattern. No elevations were observed in speciﬁc autoantibodies
(anti-DNA, anti-RNP, anti-SS-A, anti-SS-B, and anti-Scl-70 anti-
bodies) for the corresponding connective tissue diseases.
Chest X-ray showed no obvious abnormal ﬁndings; however,
HRCT demonstrated mild emphysema in the upper lung ﬁelds
(Fig. 1a). HRCT also revealed ground-glass opacity and reticular
patterns without honeycombing in the lower lung ﬁelds, which
were consistent with an NSIP pattern. A crazy-paving pattern,
which was previously reported to be frequent in non-smokers with
NSIP [3], was not observed (Fig. 1b).
Pulmonary function testing showed that VC, FVC, FEV1, and
FEV1/FVC were 3.04 L (90.7% of predicted), 2.84 L (86.9%), 2.30 L
(86.8%), and 81.0% respectively. TLC, RV, and RV/TLC were 4.80 L
(93.8%), 1.76 L (112%), and 36.7% (100%) respectively. DLCO was
14.64 mL/min/mmHg (88.9%) and DLCO/VA was 3.73/min/mmHg
(84%).
Bronchoalveolar lavage (BAL) (recovery rate; 63/150) revealed
high total cellularity (36  104 cells/ml) consisting of 22% lym-
phocytes, 2% neutrophils, and 2% eosinophils. BAL lymphocytosis
was suggestive of NSIP and transbronchial biopsies of the right lung
(rS9) showed lymphocyte inﬁltrationwith no evidence of infection.
However, the specimens obtained were insufﬁcient to allow for a
deﬁnitive diagnosis. The patient then underwent thoracoscopic
biopsy.
The main ﬁnding of the surgical biopsy specimen (rS9) was
irregular interstitial ﬁbrosis withmild chronic inﬂammation, which
ranged from the peripheral to the central part of lobule (Fig.1c). The
patchy distribution of ﬁbrotic changes seen in some subpleural
regions was similar to UIP, while the ﬁbrotic process was tempo-
rally homogenous. The lung architecture was relatively preserved
and honeycombing was not observed. These pathological ﬁndingsFig. 1. HRCT images (a-b, before surgical biopsy: f, 4 months after the cessation of smoking)
centrilobular emphysema. (b) the lower zones of the lungs showing ground-glass opacity an
emphysema in the non-ﬁbrotic lesion. (e) intraluminal accumulation of macrophages. (f) mwere consisted with that of ﬁbrotic NSIP, and centrilobular
emphysema in the non-ﬁbrotic lesion and focal intraluminal
accumulation of macrophages suggested superimposed smoking
effects (Fig. 1d,e).
Clinical, radiological, and pathological information established
the diagnosis of idiopathic NSIP. Although we planned to treat the
patient with prednisolone plus an immunosuppressive agent, he
refused the medication due to an improvement in his cough
following the complete cessation of smoking after the surgical bi-
opsy. Moreover, ground-glass opacity and reticular patterns on
HRCT were found to have gradually improved without medication
during the next 4 months (Fig. 1f) and KL-6 was reduced to 392 U/
ml. No evidence of exacerbationwas detected during the 15-month
follow-up.
Discussion
Possible pathogenic factors implicated in smoking with inter-
stitial ﬁbrosis may include oxidative stress [4], decreased HDAC2
activity [5], VEGF expression [6], and the up-regulation of TNF-a [7].
However, the impact of the cessation of smoking during the clinical
course of NSIP remains to be established. To the best of our
knowledge, this is the ﬁrst reported case of ﬁbrotic NSIP that
markedly improved without medication after the complete cessa-
tion of smoking, which suggested that smoking may be an etio-
logical factor in some patients with NSIP. The association of
emphysema with NSIP, as shown in our case, and differences in the
morphological features on HRCT between non-smokers and
smokers may support this hypothesis [3].
Differential diagnosis of this case includes DIP, combined pul-
monary ﬁbrosis and emphysema (CPFE), and smoking-related
interstitial ﬁbrosis (SRIF). DIP usually responds to corticosteroid
therapy. However, some cases progress to ﬁbrosis, despite treat-
ment [8]. In contrast, spontaneous improvement without treat-
ment was observed in 22% of patients with DIP, although the
involvement of smoking cessation was not described [9]. Previ-
ously, Kawabata et al. reported that distinct lobular distribution andand pathological ﬁndings (c-e). (a) the upper zones of the lungs showing paraseptal and
d reticular patterns. (c) irregular interstitial ﬁbrosis with mild chronic inﬂammation. (d)
arked improvements in ground-glass opacity and reticular patterns.
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characteristic features of DIP. They also found a marked increase in
the number of BAL eosionophils in patients with DIP, although the
signiﬁcance of BAL eosinophilia is not yet fully understood [8]. Our
patient did not exhibit these ﬁndings. Moreover, the prominent
accumulation of intraalveolar macrophages with diffuse distribu-
tion throughout the pulmonary acini, which is a hallmark of DIP,
was not observed in the biopsy specimen.
CPFE is a newly deﬁned syndrome, in which upper lobe
emphysema (>10% of the lung volume) coexists with signiﬁcant
pulmonary ﬁbrosis in the lower lobe deﬁned by honeycombing,
reticular opacities, and/or traction bronchiectasis on HRCT. CPFE
has been receiving considerable attention because pulmonary hy-
pertension and severe reductions in diffusion capacity are highly
prevalent in CPFE. Although the pathology of CPFE is heterogenous
including DIP, organizing pneumonia, and unclassiﬁable interstitial
pneumonia, UIP is the most common pattern and biopsy-proven
NSIP has not yet been reported [10]. The HRCT ﬁndings of our
case were milder in both emphysematous and interstitial changes
than typical CPFE. However, this casemay have progressed to a type
of CPFE if the patient continued to smoke.
Katzenstein et al. recently documented clinically occult SRIF in
lobectomy specimens. This distinct form of ﬁbrosis is composed of
thick hyalinized collagen bundles, often with variable numbers of
hyperplastic smooth muscle ﬁbers without signiﬁcant inﬂamma-
tion [11]. The pathological ﬁndings of our patient were not
consistent with these criteria.
Drug-induced NSIP is rare and NSIP may also be caused by the
inhalation of high levels of mold and/bacteria [12]. However, in our
case, no changes in drug ingestion, living environment, or habits
were reported during the clinical course, except for the complete
cessation of smoking.
The diagnosis of idiopathic NSIP in this patient was appropriate
from the above-mentioned points of issue. The reason why similar
cases have not been reported previously in spite of its relatively
high incidence rate may be that the deﬁnite diagnosis of NSIP by
surgical biopsy was not made before relatively advanced morpho-
logical abnormalities were conﬁrmed by HRCT. We performed
surgical biopsy in this patient with mild interstitial changes and
normal pulmonary function. Early smoking cessation before a
clinically detectable decline in pulmonary function may be critical
for smokers with idiopathic NSIP.Conclusion
In summary, our case suggests smoking-related pathogenesis in
some patients with idiopathic NSIP; however, the presence of un-
known factors that trigger the onset of the disease during a long
smoking habit remains elusive. More molecular biological research
is needed to obtain insights into the pathogenic factors induced by
smoking in order to clarify differences in mechanisms between
NSIP, UIP, SRIF, and other ﬁbrotic lung diseases.
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